Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Mood stabilizers for bipolar disorder can cause skin issues, but severe reactions are rare.

Alkaloids help fight influenza in animals but need more research for human use.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Alopecia areata affects about 1.93% of people worldwide, with more women affected than men.

Telogen effluvium increased globally after COVID-19, especially in Asian and Latin regions.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Spironolactone effectively treats female acne with few side effects.

Gender-affirming dermatology treatments generally improve mental well-being for transgender individuals, but more research is needed.

Finasteride is more harmful to male reproductive health than minoxidil.

Using minoxidil with microneedling increases hair count for hair loss without serious side effects.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

PRP injections may help increase hair density in women with hair loss, but more research is needed.

PRP is an effective and safe treatment for hair loss.

Spironolactone can effectively treat hair loss with manageable side effects.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Patients with central centrifugal cicatricial alopecia may have a higher risk of breast and colorectal cancer.

Familial dyskeratotic comedones are a rare, benign skin disorder that is hard to treat.

The RHD4 gene is crucial for consistent root hair growth in Arabidopsis thaliana.

Combining DHT and EDC improves the strength and stability of PADM scaffolds for tissue engineering.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

Adding stem cells to fat grafts for facial rejuvenation might improve outcomes, but more research is needed to confirm safety and effectiveness.

ICMR created standard treatment guidelines for skin diseases to improve care across India.

Aromoline and DRD4 are potential targets for osteoarthritis treatment.

Early shedding of the inner root sheath in noninflamed hair follicles is a relatively specific sign of Central Centrifugal Cicatricial Alopecia.

CCCA is a common hair loss condition in African American women, often inherited and influenced by hairstyling, with unique scalp features detectable by special tools.

KSR1 is crucial for certain skin tumor formation and could be a cancer therapy target.

Genetically modified rats help reveal how vitamin D affects bone and skin health.

A specific gene mutation is linked to a hereditary form of dystonia that responds well to certain medications.